glp 1 and vertigo GLP-1 meds like semaglutide (Ozempic/Wegovy) tirzepatide (Mounjaro/Zepbound) have been glp-1 and vertigo Electrolytes for

Future studies are needed to explore the interneural communication networks in key regions of the brain and signal transduction pathways through which GIPR antagonism recruits GLP-1R signalling

GLP-1 RAs are drugs that imitate the function of natural GLP-1, a hormone in the intestine that controls glucose metabolism and feelings of fullness

Current dual agonists under investigation also include efinopegdutide and cotadutide

However, these diseases are difficult to treat given their complexity and the challenges of drug delivery to the brain [10, 11]

Available from: Wilson A

Given the heterogeneity in study populations and the predominance of post hoc analyses, further prospective research is essential to clarify these mechanisms and to evaluate whether personalized, sex-specific approaches to GLP-1 RA therapy could improve obesity treatment outcomes